The current valuation score of VolitionRX Ltd is 9.38, ranking 35 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.29, which is 0.00% below the recent high of -0.29 and -4332.03% above the recent low of -12.72.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.